Farrell Granath

Brinker said he expects to do more with both Brookfield (51% owner) and Blackstone (20% owner), valuing the in-the-money buyback option and control of hospital relationships.

Granath asked whether the improved life science outlook has changed timing on opportunistic lab investments. Brinker said Gateway is performing well but threshold for new capital deployment is high; they need to complete in-progress recycling transactions first.

Follow-up asking to bridge lab occupancy between vacancies, new leasing, dispositions, and redevelopment. Moses noted net absorption drove Q1 occupancy gain, Salt Lake disposition removed 100% leased campus, no intention of additional lab dispositions.

Bohn explained seasonal slowdown from holidays and JPM conference prep. Pipeline 50% higher entering 2026 vs 2025 with mix shifting toward new leasing.

Moses explained Q4 NOI was propped up by security deposits and free rent burn-off. First quarter will show more pronounced impact as 77% occupancy sets into income.

Moses said tenants extending cash runways and reaching clinical milestones. Brinker added the equally important factor is improved capital-raising environment for remaining watch list.

Brinker noted AI-native biotech still uses 50/50 wet lab and office mix. AI-enabled drug discovery could reduce discovery-to-IND timeline from 5-7 years to 1 year.

Mark Theine noted 91-92% occupancy is strong, with some non-renewals from retirements or tenants outgrowing their space. No systemic pattern.

Moses cited positive signs including M&A activity (Merck, Sanofi) and secondary market reopening, but acknowledged some tenants could still fail to raise capital.

Kelvin noted 400-500bps of signed but not yet occupied leases. Pipeline is largest since last summer. Bohn added tenants are well-capitalized, not needing near-term fundraising.

Kelvin Moses acknowledged first 120 days were not ideal for capital raising but sees potential inflection from patent cliffs, regulatory stabilization and M&A.

Scott Brinker noted M&A has been constrained by FTC concerns but expects pickup under new administration, which recycles capital positively for the sector.

Pete Scott explained $500M is at the lower end of expected deployment, with a midyear time horizon. Balance sheet has capacity for more.

Joel and Marc explained advanced tech tenants are well-funded with strong credit and often fund their own build-outs. Incremental yields are similar to lab but all-in yields can be lower given lower CapEx.

Peter attributed the ~six-week shift to JV complexity and buyers taking longer to obtain available financing on non-core assets. Joel said not to read anything into the timing, pointing to last year's Q4-weighted close.

Marc explained a handful of assets considered for sale with vacancy showed good leasing interest, prompting a swap to more stabilized assets for disposition. Broader 75-90% range now includes core, noncore, and JVs.

Joel clarified the Watertown entertainment tenant was an existing renewal, not a new use. The 311 Arsenal advanced tech activity is genuine new demand, but it varies by location and building type.

Hallie noted VC deployment is steady but fund-raising at decade lows, with companies remaining conservative. Joel highlighted very small public biotech leasing in Q4 as a critical gap. Public biotech follow-ons concentrated in commercial-stage companies not driving R&D expansion.

Joel and Peter clarified the Fenway office decision was building-specific: 401 Park is an iconic office building with long-term institutional leases, and increased office demand plus available lab space elsewhere in the Fenway made office the logical path.

Marc confirmed 617,000 sqft of leased but not yet delivered space with ~$46M potential annual rental revenue, expected to deliver on average around May 1 next year.

Joel outlined three missing links to demand recovery: FDA reopening, earlier-stage venture commitments, and public biotech sector reignition. Also cited NIH funding as a factor for institutional demand.

Joel clarified the lease was driven by the pharma's desire to consolidate its West Coast R&D hub in a world-class location, not onshoring trends.

Marc noted free rent ticked up this quarter driven by one lease, and future trajectory is TBD.

Marc clarified guidance reflects current best estimate, not extreme scenarios, after Joel sought clarification on the question.

Hallie noted venture funds have ample dry powder but deployment remains judicious, focused on companies with near-term value inflection milestones.

Bob explained G&A investment in people, process, and technology to scale the platform. Expects G&A growth in line with enterprise growth.

Justin confirmed Ventas OI is fully integrated across all operators and geographies, combining data analytics with boots-on-the-ground site visits.

Hutchens said US senior housing pipeline is $35 billion and growing. Seeing more midsized deals plus continued flow business. More opportunities than a year ago.

Hutchens said 50% incremental margin in Q4, expects 50s in 2026. In-house rents at 8% vs 7% prior year. RevPOR rule of thumb is 2/3 of in-house increase. Move-in rents also improving.

Hutchens said US is top priority. Canada footprint stable, no expansion plans. UK platform set up earlier in year with CCG operator delivering excellent results, looking to expand over time.

Hutchens said Q4 sequential growth is organic, driven by strong demand and move-in volume carrying from Q3 end, not a same-store pool change.

Mitra characterized those structures as debt and pointed to sub 4% bond access as the reason Welltower would not use them.

Mitra credited Peter Kauffman of a private aerospace defense company as a key influence, emphasizing that operations is fundamentally about people, not systems. Stressed importance of filtering advice by credibility of the adviser.

Nikhil framed SNF as structured credit investments that are short-dated by nature: acquire, stabilize with regional operators, exit to HUD financing, redeploy proceeds opportunistically.

Shankh explained the participating structure hedges against selling at wrong point in cycle while redirecting management focus to senior housing digital transformation.